Interactions between microenvironment and cancer cells in two animal models of bone metastasis

British Journal of Cancer

Volumn 98, Issue 4, 2008, Pages 809-815

  Blouin, S ^a   Basle M F ^a   Chappard, D ^a  

^a INSERM   (France)

Author keywords

Bone metastasis; Microenvironment; Osteoclast; Osteoclastogenesis; Osteolysis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; COLONY STIMULATING FACTOR 1; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; PROTEIN DICKKOPF 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE METASTASIS; CANCER CELL; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; COPENHAGEN RAT; FEMALE; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MICROENVIRONMENT; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROMA CELL; SUBCUTANEOUS TISSUE TUMOR;

EID: 39449138376     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604238     Document Type: Article

References (45)

1. Baron R, Neff L, Tran Van P, Nefussi JR, Vignery A (1986) Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 122: 363-378
2. Bierie B, Moses HL (2006) Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520
3. Blouin S, Basle MF, Chappard D (2005) Rat models of bone metastases. Clin Exp Metastasis 22: 605-614
4. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423: 337-342
5. Chappard D, Alexandre C, Riffat G (1983) Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem 27: 75-85
6. Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27: 165-176
7. Cooper CR, Chay CH, Gendernalik JD, Lee HL, Bhatia J, Taichman RS, McCauley LK, Keller ET, Pienta KJ (2003) Stromal factors involved in prostate carcinoma metastasis to bone. Cancer 97: 739-747
8. Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R (2000) Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85: 800-805
9. Guise TA (2000) Molecular mechanisms of osteolytic bone metastases. Cancer 88: 2892-2898
10. Guise TA, Mundy GR (1998) Cancer and bone. Endocr Rev 19: 18-54
11. Guise TA, Yin JJ, Mohammad KS (2003) Role of endothelin-1 in osteoblastic bone metastases. Cancer 97: 779-784
12. Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM (2000) Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem 48: 219-228
13. Johnson ML, Harnish K, Nusse R, Van Hul W (2004) LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 19: 1749-1757
14. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401
15. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549
16. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS (2001) Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Met Rev 20: 333-349
17. Lee Y, Schwarz E, Davies M, Jo M, Gates J, Wu J, Zhang X, Lieberman JR (2003) Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res 21: 62-72
18. Libouban H, Moreau MF, Basle MF, Bataille R, Chappard D (2003) Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone 33: 283-292
19. Libouban H, Moreau MF, Basle MF, Bataille R, Chappard D (2004) Selection of a highly aggressive myeloma cell line by an altered bone microenvironment in the C57BL/KaLwRij mouse. Biochem Biophys Res Commun 316: 859-866
20. Logothetis CJ, Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21-28
21. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56
22. Mundy GR (1997) Mechanisms of bone metastasis. Cancer 80: 1546-1556
23. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593
24. Mundy GR, Chen D, Zhao M, Dallas S, Xu C, Harris S (2001) Growth regulatory factors and bone. Rev Endocr Metab Disord 2: 105-115
25. Murata A, Fujita T, Kawahara N, Tsuchiya H, Tomita K (2005) Osteoblast lineage properties in giant cell tumors of bone. J Orthop Sci 10: 581-588
26. Rabbani SA, Gladu J, Harakidas P, Jamison B, Goltzman D (1999) Overproduction of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer 80: 257-264
27. Reis FM, Luisi S, Carneiro MM, Cobellis L, Federico M, Camargos AF, Petraglia F (2004) Activin, inhibin and the human breast. Mol Cell Endocr 225: 77-82
28. Risbridger GP, Mellor SL, McPherson SJ, Schmitt JF (2001) The contribution of inhibins and activins to malignant prostate disease. Mol Cell Endocr 180: 149-153
29. Rizzoli R, Fleisch H (1987) The Walker 256/B carcinosarcoma in thyroparathyroidectomized rats: a model to evaluate inhibitors of bone resorption. Calcif Tissue Int 41: 202-207
30. Roodman GD (2003) Role of stromal-derived cytokines and growth factors in bone metastasis. Cancer 97: 733-738
31. Roodman GD (2004) Mechanisms of bone metastasis. N Eng J Med 350: 1655-1664
32. Schneider A, Kalikin LM, Mattos AC, Keller ET, Allen MJ, Pienta KJ, McCauley LK (2005) Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 146: 1727-1736
33. Shimamura T, Amizuka N, Li M, Freitas PH, White JH, Henderson JE, Shingaki S, Nakajima T, Ozawa H (2005) Histological observations on the microenvironment of osteolytic bone metastasis by breast carcinoma cell line. BiomedRes 26: 159-172
34. Teot LA, O'Keefe RJ, Rosier RN, O'Connell JX, Fox EJ, Hicks DG (1996) Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. Hum Pathol 27: 625-632
35. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ, Gillespie MT (1999) Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140: 4451-4458
36. Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L, Kovalszky I (2002) Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol 12: 173-186
37. Vaaraniemi J, Halleen JM, Kaarlonen K, Ylipahkala H, Alatalo SL, Andersson G, Kaija H, Vihko P, Vaananen HK (2004) Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res 19: 1432-1440
38. van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Lowik C (2001) Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J Bone Min Res 16: 1077-1091
39. Vieweg J, Rosenthal FM, Bannerji R, Heston WD, Fair WR, Gansbacher B, Gilboa E (1994) Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res 54: 1760-1765
40. Weinberg ED (1983) Iron in neoplastic disease. Nutr Cancer 4: 223-233
41. Wingen F, Eichmann T, Manegold C, Krempien B (1986) Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat. J Cancer Res Clin Oncol 111: 35-41
42. Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80: 1529-1537
43. Yam LT, Janckila AJ, Li CY, Lam WK (1987) Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience. Leukemia 1: 285-288
44. Yasuda Y, Kaleta J, Bromme D (2005) The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev 57: 973-993
45. Zigrino P, Loffek S, Mauch C (2005) Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87: 321-328